We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
The Best of the Best |

Top-Accessed Article: Psoriasis Associated With Hyperleptinemia FREE

Joel M. Gelfand, MD, MSCE
Arch Dermatol. 2010;146(9):1057. doi:10.1001/archdermatol.2010.202.
Text Size: A A A
Published online

Chen YJ, Wu CY, Shen JL, Chu SY, Chen CK, Chang YT, Chen CM. Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome. Arch Dermatol. 2008;144(12):1571-1575.

In the last 4 years, several large population-based epidemiological studies have suggested that psoriasis, especially when severe, may be an independent risk factor for heart attack, stroke, cardiovascular death, atherosclerosis, and diabetes. Chen and colleagues demonstrated in a small clinic-based cross-sectional study that psoriasis may be an independent risk factor for increased levels of serum leptin, an adipocyte-derived hormone that is involved in the regulation of metabolism and inflammation. The severity of psoriasis was not associated with statistically significant increases in leptin levels. Based on the design of the study, the directionality of the association cannot be determined. Moreover, the clinical significance of elevated leptin as defined by this study is unclear. In particular, in multivariable analysis, the odds ratio (OR) of increased leptin was similar in psoriasis (OR, 4.47; 95% confidence interval [CI], 1.47-14.23) and metabolic syndrome (OR, 4.37; 95% CI, 1.06-17.96), but the most significant risk factor was female sex (OR, 26.36; 95% CI, 7.41-93.75). Additional studies evaluating inflammatory cardiovascular risk biomarkers in patients with psoriasis are indicated.

From June 2004 through August 2009, this article was viewed 2277 times on the Archives of Dermatology Web site.

Contact Dr Gelfand at Department of Dermatology, Center for Clinical Epidemiology and Biostatistics, Hospital of the University of Pennsylvania, One Convention Avenue, 1471 Penn Tower, Philadelphia PA 19104 (joel.gelfand@uphs.upenn.edu).





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.